Check out our most popular compounded medications! Get Started
Bayview Pharmacy's Pergolide 1 mg/5 ml Oral Suspension (Vet-Equine) is a compounded formulation designed to treat conditions such as Cushing's Disease, Equine Pituitary Pars Intermedia Dysfunction, Hyperadrenocorticism, Hyperinsulinemia, and Equine Metabolic Syndrome. This medication is a liquid dosage form, ensuring a uniform dispersion of ingredients for effective administration.
Licensed to fill prescriptions for patients in RI, MA, CT, NJ, NH, FL, ME and PA. New York patients are served on a limited basis while nonresident registration is pending.
Bayview Pharmacy is pleased to provide Pergolide 1 mg/5 ml Oral Suspension (Vet-Equine), a compounded formulation designed specifically for the treatment of various equine conditions such as Cushing's Disease, Equine Pituitary Pars Intermedia Dysfunction, Hyperadrenocorticism, Hyperinsulinemia, and Equine Metabolic Syndrome. Pergolide, a dopamine agonist, functions by reducing the production of hormones that trigger these conditions.
This medication is a liquid dosage form in which one or more ingredients are uniformly dispersed throughout a liquid medium, creating a homogeneous mixture for administration. Pergolide 1 mg/5 ml Oral Suspension (Vet-Equine) is administered orally, typically once a day. The dosage and duration of treatment are determined by the severity of the condition and the horse's response to treatment. It is crucial to adhere to your veterinarian's instructions and to closely monitor your horse's reaction to the medication.
If you have any inquiries about Pergolide 1 mg/5 ml Oral Suspension (Vet-Equine) or any other compounded medications, please do not hesitate to contact us at Bayview Pharmacy. We are here to provide support and answer any questions you may have regarding your horse's medication and treatment plan.
This compounded formulation of Pergolide 1 mg/5 ml Oral Suspension (Vet-Equine) is a liquid dosage form that provides a homogeneous mixture for administration. It is specifically designed for the treatment of various equine conditions such as Cushing's Disease, Equine Pituitary Pars Intermedia Dysfunction, Hyperadrenocorticism, Hyperinsulinemia, and Equine Metabolic Syndrome. The active ingredient, Pergolide, is a dopamine agonist that functions by inhibiting the release of hormones from the pituitary gland. This action helps to alleviate the symptoms associated with these conditions.
It is crucial to be aware that Pergolide should not be administered to horses with a known hypersensitivity to the drug or any of its components. It is also contraindicated in horses with hepatic or renal impairment. The horse's response to the medication should be closely monitored, and the dose should be adjusted as necessary to ensure optimal therapeutic outcomes. If there are any questions or concerns regarding this formulation or its use, we encourage you to contact us for further information.
Pergolide 1 mg/5 ml Oral Suspension (Vet-Equine) is a compounded formulation designed specifically for the treatment of various equine conditions such as Cushing's Disease, Equine Pituitary Pars Intermedia Dysfunction, Hyperadrenocorticism, Hyperinsulinemia, and Equine Metabolic Syndrome. This oral medication functions by inhibiting the release of hormones from the pituitary gland, thereby alleviating the symptoms associated with these disorders.
The medication is typically administered once daily, although the dosage may require adjustment based on the individual horse's response to the treatment. It is crucial to closely observe the horse's reaction to the medication and modify the dosage as necessary. The most common side effects observed with pergolide use include a decrease in appetite, weight loss, and an increase in thirst. If any of these side effects are noted, it is essential to immediately contact your veterinarian for advice.
Adherence to the instructions provided by your veterinarian when administering this medication is of utmost importance to ensure its effectiveness and the safety of your horse. If you have any queries or concerns regarding this formulation or its mechanism of action, please do not hesitate to contact us for further information.
The Pergolide 1 mg/5 ml Oral Suspension (Vet-Equine) is a compounded formulation specifically designed for the treatment of various equine conditions. These include Cushing's Disease, Equine Pituitary Pars Intermedia Dysfunction, Hyperadrenocorticism, Hyperinsulinemia, and Equine Metabolic Syndrome. It is also utilized to mitigate the risk of laminitis in horses diagnosed with Cushing's Disease.
This formulation is presented in a liquid dosage form, ensuring a uniform dispersion of the active ingredient, Pergolide, throughout the liquid medium. This provides a homogeneous mixture for easy and accurate administration. The product is packaged in a 5 ml bottle for convenience and precision.
The recommended dosage for this formulation is 0.1 mg/kg body weight, administered once daily. It is crucial to administer this medication orally, as per the prescribed dosage, to ensure its effectiveness.
However, it is important to exercise caution while using this formulation. It is not recommended for horses with known hypersensitivity to pergolide or any other ingredients present in the formulation. Furthermore, it should not be administered to horses with hepatic or renal impairment, as it may exacerbate their condition.
If you have any queries or require further information regarding the use of this formulation, please do not hesitate to contact us. We are here to assist you in providing the best possible care for your equine companions.
Pergolide 1 mg/5 ml Oral Suspension (Vet-Equine) is a liquid dosage form of medication used in veterinary medicine. It contains the active ingredient Pergolide, which is uniformly dispersed throughout a liquid medium to provide a homogeneous mixture for administration.
This medication is administered orally. The uniform dispersion of the active ingredient in the liquid medium ensures that the correct dose is delivered with each administration.
The liquid medium serves as a carrier for the active ingredient, Pergolide. It allows for the uniform dispersion of the medication, ensuring that each dose contains the correct amount of the active ingredient.
Yes, Pergolide 1 mg/5 ml Oral Suspension (Vet-Equine) is a homogeneous mixture. This means that the active ingredient is evenly distributed throughout the liquid medium, ensuring consistent dosing.
The active ingredient in this medication is Pergolide. It is dispersed uniformly throughout the liquid medium in the suspension.
The concentration of Pergolide in this formulation is 1 mg per 5 ml of the suspension. This means that for every 5 ml of the liquid, there is 1 mg of Pergolide.
This medication is intended for use in equines, as indicated by the name Vet-Equine. It is commonly used in horses.
Pergolide is commonly used to treat conditions such as Cushing's disease in horses. However, the specific conditions it is used to treat can vary, and it should only be used under the direction of a veterinarian.
While this medication is intended for use in equines, it may be used in other animals under the direction of a veterinarian. However, the dosage may need to be adjusted based on the animal's size and the condition being treated.
If you miss a dose, give it as soon as you remember. If it is close to the time for the next dose, skip the missed dose and go back to the regular dosing schedule. Do not give two doses at once. Always consult with your veterinarian if you have any concerns.
This formulation is compounded by Bayview Pharmacy on a prescriber's order for an individual patient. It is not an FDA-approved drug product, and the FDA has not evaluated it for safety, effectiveness, or manufacturing quality.
The conditions listed on this page are indications prescribers have ordered this preparation for. They are not FDA-approved indications, and listing them is not a statement that this preparation is effective for them.
A valid prescription is required. Availability depends on Bayview's licensure in your state. This page is general information, not medical advice — discuss your situation with a licensed healthcare provider.
Search by NCPDP 4106882, or by name and ZIP: Bayview Pharmacy, Warwick, RI 02886. Select it as the destination pharmacy and save it as a favorite. Click any value to copy it.
Compounded preparations have no NDC, so this formula will not appear in your EHR's drug search. Use your system's compound, non-formulary, or free-text prescription entry and name the preparation exactly as written in step 3. If your EHR forces you to pick a listed drug, pick the closest entry for the active ingredient and put the full formula in the prescription body (the Sig or directions field), not in Notes to Pharmacy.
Compounded preparations have no NDC and will not appear in your drug search. For EPCS to validate, select a drug entry your EHR recognizes as controlled, usually the bulk powder entry for the active ingredient (for example Ketamine (bulk) powder, not a branded product), then put the full formula from step 3 in the prescription body. A free-text entry that does not validate as controlled will be rejected by your EPCS module.
Quantity and directions are starting points for this dose form, not treatment recommendations. Dosing remains the prescriber's responsibility.
Transmit from your EHR. For this non-controlled preparation we also accept fax to (401) 284-4506 and phoned orders at (401) 284-4505. Order forms are on the formulation pages and in the prescriber portal.
Transmit with two-factor authentication through your EPCS-enabled EHR. No order form is offered for this preparation; e-prescribing guides for our controlled preparations are on the formulation pages.
Licensed to dispense in RI, MA, CT, NJ, NH, FL, ME, and PA; New York is served on a limited basis while nonresident registration is pending. Compounded preparations are not FDA-approved. A valid prescription is required. Full guide, including steps by EHR: How to e-prescribe to Bayview. Questions about this formula: call (401) 284-4505.
Take orally
